By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biodesix, Inc. 

2970 Wilderness Place
Suite 100
Boulder  Colorado  80301  U.S.A.
Phone: 303-417-0500 Fax: n/a



Company News
Biodesix, Inc. Presents Cell-Free DNA Process Optimization For Liquid Biopsy Test 8/9/2017 11:46:17 AM
Biodesix, Inc. And Positive Bioscience Announce Partnership To Bring Cancer Tests To India 6/12/2017 11:46:48 AM
AVEO Oncology (AVEO) And Biodesix, Inc. Announce Results From Two Investigator-Sponsored Phase I Studies Of HGF Targeted Antibody Ficlatuzumab At The 2017 ASCO Annual Meeting 6/6/2017 8:11:14 AM
Biodesix, Inc. Release: New Study Shows Advanced Diagnostic Tests, Including The Veristrat Test, Can Help Physicians Improve Cancer Care Planning And Reach Quality Measures For Patients 5/23/2017 11:21:09 AM
New Data Show Biodesix, Inc.’s VeriStrat Test Is Cost-Saving, Improves Survival And Quality Of Life In Advanced Lung-Cancer Patients 4/4/2017 2:49:47 PM
Blood-Based Diagnostic Assay From Biodesix, Inc. Measures Immunotherapy Biomarker PD-L1 2/27/2017 11:33:13 AM
Biodesix, Inc. Release: GeneStrat Liquid Biopsy Testing Now Includes ROS1 And RET Mutations 2/2/2017 10:27:27 AM
Biodesix, Inc. Release: Clin-TOF Successfully Integrated Into VeriStrat Workflow 1/27/2017 7:02:49 AM
Beijing's Bioyong Forms $38 Million IVD Collaboration With Biodesix, Inc. 1/12/2017 11:11:12 AM
Biodesix, Inc. And Bioyong Announce Agreement For Joint Development And Commercialization Of Veristrat Test In Greater China 1/9/2017 11:10:10 AM